Streetbeat News

Regulatory

GSK

GSK has submitted a marketing application to the FDA for gepotidacin, a new oral antibiotic for urinary tract infections, which could be the first in its class in over 20 years. The FDA has granted Priority Review with a decision expected by March 2025. Gepotidacin showed promising results in phase 3 trials, outperforming the current standard treatment, nitrofurantoin.

Portfolio Pulse from Vandana Singh

October 16, 2024 | 3:35 pm

BTCUSD

A policy scorecard by Alex Thorn from Galaxy Research evaluates the crypto positions of Joe Biden, Kamala Harris, and Donald Trump. Trump is seen as the most favorable for the crypto industry, with potential benefits for altcoins. Biden's administration is viewed as hostile, while Harris shows a mixed but potentially supportive stance.

Portfolio Pulse from Khyathi Dalal

October 16, 2024 | 2:50 pm

FBTC

IBIT

Bitcoin Cash (BCH) has surged 14% due to increased inflows into Bitcoin and Ethereum ETFs, driven by U.S. political dynamics favoring cryptocurrencies. This has also boosted interest in altcoins like Bitcoin Cash.

Portfolio Pulse from Henry Khederian

October 16, 2024 | 2:48 pm

AMD

INTC

IVV

QCOM

VOO

Intel's stock is under pressure due to Qualcomm's postponed strategic offer and a cybersecurity probe by China. Qualcomm's potential acquisition of Intel faces antitrust scrutiny, while Intel struggles with market share loss and AI transition. Intel's stock is down 3.3%.

Portfolio Pulse from Anusuya Lahiri

October 16, 2024 | 2:42 pm

ETHUSD

Anthony Scaramucci criticized Donald Trump's World Liberty Financial (WLFI) DeFi project as a 'money scam' and advised investors to avoid it. Despite skepticism from figures like Mark Cuban, the WLFI token sale reached $220 million in its first hour. The project aims to raise $300 million with 100 billion tokens on the Ethereum blockchain.

Portfolio Pulse from Ivan Crnogatić

October 16, 2024 | 2:09 pm

ABT

An Abbott executive reported that a judge in a trial concerning the company's pediatric products has prevented a joint statement and report from the FDA, CDC, and HHS from being included as evidence.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2024 | 1:47 pm

BTCUSD

ETHUSD

USDCUSD

XRPUSD

The cryptocurrency industry is significantly influencing the 2024 U.S. election cycle by contributing large sums to both Republican and Democratic candidates. Crypto-linked PACs and donors have raised substantial funds, with notable contributions from industry leaders like David Bailey and Chris Larsen. The industry's strategy focuses on supporting candidates favorable to crypto interests without making cryptocurrency a central campaign issue.

Portfolio Pulse from Ivan Crnogatić

October 16, 2024 | 1:32 pm

CGEM

Cullinan Therapeutics shares rose after the FDA approved their IND application for CLN-978.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2024 | 1:29 pm

FBLG

FibroBiologics has been granted a European patent for its fibroblast delivery system of tumor inhibitory agents, potentially enhancing its market position in cancer treatment technologies.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2024 | 1:20 pm

NVAX

The FDA has placed a clinical hold on Novavax's COVID-19-influenza combination vaccine trial due to a serious adverse event reported in a participant. This has led to a significant drop in Novavax's stock price.

Portfolio Pulse from Vandana Singh

October 16, 2024 | 1:16 pm